ESSA Pharma Inc (EPIX) Reports Q1 Fiscal 2024 Financial Results

Continued Clinical Progress and Strong Cash Position Highlighted

Related Keywords

,Development Expenses ,Pharma Inc ,Financial Strength ,Administrative Costs ,Essa Pharma Inc ,Ash And Cash Equivalents ,Hareholders 39 Equity ,Clinical Programs ,Financial Results ,Cash Position ,Clinical Advancements ,Prostate Cancer ,